Literature DB >> 2867813

Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine.

O A Ramirez, R Y Wang.   

Abstract

Extracellular single-unit recording techniques were used to determine whether chronic treatment with either a typical antipsychotic drug (APD), haloperidol (HAL) or an atypical APD clozapine (CLOZ) causes a time-dependent reduction of spontaneously active norepinephrine (NE) neurons in the locus coeruleus (LC). Neither HAL nor CLOZ, after prolonged treatment, reduced NE activity. In addition, subchronic amphetamine (AMP) treatment did not increase NE activity. If these results can be extended to humans, they suggest that NE hyperactivity is not the cause for schizophrenic symptoms. Interestingly, chronic CLOZ markedy increased NE activity which may contribute to its low potential for causing extrapyramidal side-effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867813     DOI: 10.1016/0006-8993(86)91411-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task.

Authors:  Ee Peng Lim; Vivek Verma; Rajini Nagarajah; Gavin S Dawe
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder.

Authors:  Matthew A Seager; Vanessa N Barth; Lee A Phebus; Kurt Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

Review 3.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.

Authors:  M Carlsson; A Svensson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

5.  Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating.

Authors:  Karen M Alsene; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

6.  Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.

Authors:  M Carlsson; A Carlsson
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

7.  On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

Authors:  Paola Devoto; Giovanna Flore
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

8.  Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.

Authors:  Paola Devoto; Giovanna Flore; Giada Vacca; Luigi Pira; Alessandra Arca; Maria Antonietta Casu; Luca Pani; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

9.  Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.

Authors:  A Muñoz; A Lopez-Real; J L Labandeira-Garcia; M J Guerra
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

10.  Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study.

Authors:  Chris A Oosterhof; Mostafa El Mansari; Christoffer Bundgaard; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.